AIDS
Pixabay

A new study, published in the journal AIDS, has revealed that the human immunodeficiency virus (HIV) directly impacts the brain in the early stages of the infection.

A team of researchers from Stellenbosch University (SU) in South Africa compared the brain activity of people with HIV to those without HIV using functional magnetic resonance imaging (fMRI) to conduct the study.

"Our research shows that HIV does have an impact on the brain and that these low-grade cognitive symptoms are likely not just function loss due to patients feeling sick, tired or depressed," Stefan du Plessis of Stellenbosch University (SU) in South Africa told IANS.

It has long been known that many people with HIV also experience negative cognitive symptoms, such as depression and forgetfulness. However, it was not clear whether it was caused by such patients' physical illness, or whether the human immunodeficiency virus had a direct effect on the brain.

Du Plessis and his team performed certain tasks designed to stimulate specific regions of the brain.

The HIV-positive study participants were in good physical and mental health, did not abuse drugs, and had not yet started on anti-retroviral treatment (ART). According to the study, these participants had a decreased blood flow in the striatal region of the brain while performing tasks involving higher motor functions.

The researchers also noted that the HIV-positive patients were having little action and blood flow to the nucleus accumbens while performing a task involving a monetary reward. This particular section the brain is involved with aspects concerning motivation, apathy and enthusiasm for life.

"The fMRI scans show how the HI virus affects important parts of the brain involved with motivation," Du Plessis said. "We theorise that this could happen to such an extent that patients are often simply not motivated enough to take their medication, or even get out of bed," he further added.

The scientists believe that these results will surely stimulate further studies to test the effects of ARVs (anti-retroviral drug used to treat infections in the management of HIV/AIDS), or other interventions, which could eventually improve brain function and therefore the lives and well-being of patients with HIV.

(With inputs from Indo-Asian News Service)